YPOSKESI
Yposkesi is a European industrial leader for Gene and Cell Therapy with the mission of developing, manufacturing and making available Gene and Cell therapy treatments to patients affected with rare diseases. It was launched in November 2016 in Corbeil Essonnes (South of Paris, France) by the patient organization AFM-Téléthon with the support of the SPI fund from the French Public Investment Bank (BPI France), with a total investment of €121M. It is made up of 160 experts in bioproduction and... has a first production building covering 5,000 m2. The broad expertise of Yposkesi covers the production of viral vectors for gene therapy (Lentivirus & AAV) and the transduction of hematopoietic stem cells, with also significant efforts in developing innovative technologies for large-scale cost-effective manufacturing of these highly complex ATMPs. The plans are to extend the production capacity with two additional buildings for a total of 13’000 m2 by 2021.
YPOSKESI
Social Links:
Industry:
Biotechnology Health Care Life Science Manufacturing
Founded:
2016-01-01
Address:
Corbeil-essonnes, Ile-de-France, France
Country:
France
Website Url:
http://www.yposkesi.com
Total Employee:
101+
Status:
Active
Contact:
+33 760 113 938
Email Addresses:
[email protected]
Technology used in webpage:
HSTS IPv6 Nginx Person Schema Facebook Sharer Gravatar Profiles ASP.NET IIS Microsoft Ubuntu
Similar Organizations
BioVectra
BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechn, contract development & manufacturing provider for preclinical, clinical and commercial biologics manufacturing.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Current Employees Featured
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-12 | Yposkesi reinforces team with three executive appointments |
Official Site Inspections
http://www.yposkesi.com Semrush global rank: 3.18 M Semrush visits lastest month: 4.72 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "YposKesi"
The story and experts of the biggest european's CDMO …
Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for cell and gene therapy viral vector manufacturing. As a trusted partner for biotechs and pharma …See details»
YposKesi - Crunchbase Company Profile & Funding
Yposkesi is a European Contract Development & Manufacturing Organization (CDMO) for Gene and Cell Therapy - Lentivirus & AAV viral vectors.See details»
Meet our leadership team - Yposkesi
Christel Rivière, PhD, joined Yposkesi as Director of CMC project management in 2016. With over 20 years of experience in the gene therapy field, she started her career at the Gene Therapy …See details»
Yposkesi, an SK pharmteco Company - Genopole
Yposkesi, an SK pharmteco Company, is the first French company to develop and manufacture gene and cell therapy products for rare diseases.See details»
Yposkesi - Overview, News & Similar companies | ZoomInfo.com
Jun 22, 2023 Who is Yposkesi Yposkesi is a leading Contract Development & Manufacturing Organization (CDMO) for gene therapy vector manufacturing. Created in November 2016 in C …See details»
Company profile | Yposkesi | My Biologics Partner
About us Contract and Development Manufacturing Organization specialised in the manufacturing of gene therapy drugsSee details»
Yposkesi Company Profile - Office Locations, Competitors, …
Yposkesi is a contract development and manufacturing organization specializing in gene therapy viral vector manufacturing. It offers bioprocess development, upstream and downstream …See details»
Yposkesi - Products, Competitors, Financials, Employees, …
About Yposkesi Yposkesi, a joint venture between AFM-Telethon and the SPI fund, is a France-based, contract development and manufacturing organization (CDMO) with goals to make …See details»
Your project | Yposkesi - Yposkesi
The project management is following a few steps: Organization of a kick-off meeting: to review your project content (work packages definition with technical content, pre-requisites and expected outcome, deliverables, milestones…), …See details»
Yposkesi Company Profile 2024: Valuation, Investors, …
Information on acquisition, funding, investors, and executives for Yposkesi. Use the PitchBook Platform to explore the full profile.See details»
Yposkesi Breaks Ground for Second Plant - SK pharmteco
Yposkesi has begun the construction of its second drugmaking plant in France to ramp up its manufacturing capacity. In March, SK Inc. acquired a 70 percent stake in Yposkesi, a France …See details»
Yposkesi - Company Profile - Tracxn
Oct 23, 2024 Yposkesi - Manufacturer of gene and cell therapy products. Acquired by SK. Raised funding from 1 investor.See details»
YposKesi - Updates, News, Events, Signals & Triggers
Yposkesi is a European Contract Development & Manufacturing Organization (CDMO) for Gene and Cell Therapy - Lentivirus & AAV viral vectors.See details»
Yposkesi's story - YouTube
Have you already wonder what "Yposkesi" means, how we gained our viral vector manufacturing expertise and what our next steps are? Watch this video to learn more about us and our …See details»
Yposkesi launches construction of its second bioproduction site.
Jun 14, 2021 Corbeil-Essonnes (near Paris), France, June 14, 2021– Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene …See details»
Pharma's Almanac: Nice Insight's Content Community
Overview Yposkesi is a leading Contract Development & Manufacturing Organization (CDMO) for gene therapy vector manufacturing. Created in November 2016 in Corbeil-Essonnes (France) …See details»
SK acquires 70% stake in Yposkesi to jump into cell, gene CMO …
SK Inc., the holding and investment company of SK Group, South Korea’s third-largest conglomerate, has acquired a 70% stake in Yposkesi, a French bio contract manufacturing …See details»
Leading innovation to industrial production of gene therapy
Large-scale manufacturing of viral vectors in a cost-efficient manner is certainly one of the key challenges that the bioproduction of gene therapy products is facing today. Constantly …See details»
YposKesi - Contacts, Employees, Board Members, Advisors & Alumni
Yposkesi is a European Contract Development & Manufacturing Organization (CDMO) for Gene and Cell Therapy - Lentivirus & AAV viral vectors.See details»